Guardant Health director Bahija Jallal to resign at June 2022 annual meeting

Guardant Health, Inc.

Dr. Bahija Jallal notified Board on May 4, 2022 of her resignation as director, effective June 15, 2022 Annual Meeting.
Resignation is not due to any dispute or disagreement with the company on operations, policies, or practices.
No replacement director announced in the filing; board composition will change effective June 15.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Bahija Jallal

Director

GH · Guardant Health, Inc.

Effective: 2022-06-15
Filed: May 6, 2022, 7:59 PM ET

On May 4, 2022, Dr. Bahija Jallal notified the Board of Directors (the “Board”) of Guardant Health, Inc. (the “Company”) of her decision to resign as a director of the Company, effective as of the Company’s next Annual Meeting of Stockholders, which will take place on June 15, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bahija Jallal resigned as Director at Guardant Health, Inc..

Action: resigned
Role: Director

Exact text from the filing

On May 4, 2022, Dr. Bahija Jallal notified the Board of Directors (the “Board”) of Guardant Health, Inc. (the “Company”) of her decision to resign as a director of the Company, effective as of the Company’s next Annual Meeting of Stockholders, which will take place on June 15, 2022.

View on SEC.gov

Guardant Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-142536

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.